|
PB 118 of 2022
Determinations/Health as made
|
|
This instrument amends the National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022) by increasing and imposing claimed prices and brand premiums for multiple brands of specified pharmaceutical items. In addition, it removes one brand of one pharmaceutical item due to product discontinuation.
|
|
Administered by: Health and Aged Care
|